Industry Non-CME (INC) Programs
Discover exciting industry innovations during platinum- and gold-sponsored programming throughout the event.
The Industry Non-CME (INC) Programs at the 2025 AAD Annual Meeting are your chance to learn about the latest innovations directly from industry. At the sponsoring company’s discretion, these sessions present new research findings, showcase specialty innovations, conduct demonstrations, and host lively discussions.
Pre-registration is required, and food and beverage are provided by the sponsoring company. INC Programs take place in the evening after education sessions and are exclusively developed and delivered by the sponsor. They do not qualify for continuing medical education credit.
The full agenda for the INC Programs is available below and online. Be sure to check out the stimulating sessions, topics, and speakers lined up for the event.
Please note: There will be no sessions Friday, March 7.
Thursday, March 6, 2025
Chronic Hand Eczema: A New Day is at Hand
Platinum sponsor: Leo Pharma Inc.
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Regency Ballroom T
This dermatology conference symposium is focused on the increasingly recognized condition of chronic hand eczema (CHE), featuring a panel of three international experts who will share their insights and expertise on CHE. This symposium will provide a comprehensive exploration of the background of this prevalent condition including its subtypes, pathophysiology, burden on patients, treatment strategies and management tips. Join us for this informative and engaging symposium to enhance your understanding of chronic hand eczema and improve patient care.
Register: https://forms.office.com/e/By8UyL3zW6
THIAMIDOL: A Breakthrough Innovation in Dark Spot Correction
Platinum sponsor: Beiersdorf
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Regency Ballroom U
Explore Thiamidol: A groundbreaking innovation that will transform dark spot correction. Learn about Thiamidol, its science, and clinical data-including real-world evidence.
Inside Psoriasis: A Focus on Advanced, Targeted Systemic Therapy
Gold sponsor: Medscape
6:30 p.m. Registration; 7 p.m. Program
Location: Convention Center, Room W224EFGH
Join us for a newsroom style symposium on systemic psoriasis treatment, designed to foster audience participation and provide valuable insights from experts in the field. A faculty host and expert panelists will report the latest on recent data updates, patient burden and quality of life, and systemic treatment guidance. Chat with our roving reporter about your perspectives on psoriasis and connect with fellow clinicians! Don’t miss out on this interactive and informative newsroom program!Presented through a collaboration between International Psoriasis Council (IPC) and Medscape Education.Supporter Statement: Supported by an independent educational grant from AbbVie.
Register: www.medscape.org/sympo/inside-psoriasis
Elevating Care in Moderate to Severe Atopic Dermatitis: Case Challenges
Gold sponsor: Medscape
6:30 p.m. Registration; 7 p.m. Program
Location: Convention Center, Room W221ABCDE
Are you keeping pace with the rapidly evolving landscape of atopic dermatitis (AD) management? Don't miss this opportunity to engage with case challenges that will test your clinical acumen and spark debates among peers. Join us for this interactive symposium that will help you refine your approach to atopic dermatitis management and improve your patient outcomes. You won’t want to miss this unique case challenge program!Presented through a collaboration between Society of Dermatology Nurse Practitioners (SDNP) and Medscape Education.Supported by an independent educational grant from AbbVie.
Register: www.medscape.org/sympo/atopic-derm-2025
Saturday, March 8, 2025
What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP
Platinum sponsor: Sanofi and Regeneron
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Regency Ballroom T
Type 2 inflammation contributes to many dermatologic diseases, which may lead to potentially life-changing burdens and challenges to patients and caregivers. By uncovering the role of type 2 inflammation in the pathophysiology of AD, PN, CSU, and BP, we can move forward in our understanding of each disease. Join experts Eric Simpson, Shawn Kwatra, Victoria Werth, and Jason Hawkes on March 8 for an educational symposium, “What Went Wrong? How Dysregulated Type 2 Immunity Contributes to AD, PN, CSU, and BP”. Don’t miss your opportunity to hear directly from global experts during the meet-the-experts session following the presentations.
Understanding Vitiligo: Exploring the Patient Experience
Platinum sponsor: Pfizer Inc.
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Regency Ballroom U
Join Pfizer for an engaging and informative symposium exploring the lived experiences of individuals with vitiligo. Hear directly from a patient about their unique journey, challenges, and triumphs. Our esteemed faculty will provide expert context on the impact of vitiligo and discuss the evolving landscape of care. Gain valuable insights and foster a deeper understanding of this complex condition.
Clarifying Pathways in the Treatment of Atopic Dermatitis with Biologics
Gold sponsor: Eli Lilly and Company
6:30 p.m. Registration; 7 p.m. Program
Location: Convention Center, Room W221ABCDE
The evolving treatment landscape in atopic dermatitis (AD) is being guided by the expanding knowledge of the underlying mechanisms driving disease pathogenesis and key mediators of skin and itch manifestations. Dr Gil Yosipovitch, Dr Diamant Thaçi, and Dr Jonathan Silverberg will review immunological pathways involved, the role of specific cytokines, and the differences in mechanisms of action of biologic treatments. The session will also focus on the treatment landscape by reviewing specific features in the clinical profiles of approved biologics in AD.
The Patient’s Voice: Guiding the Path to Address Unmet Needs in Psoriasis
Gold sponsor: Johnson & Johnson
6:30 p.m. Registration; 7 p.m. Program
Location: Convention Center, Room W224EFGH
Join us for an engaging and thought-provoking symposium that delves into the ongoing challenges and care gaps experienced by patients with moderate to severe plaque psoriasis. Unmet needs in moderate to severe plaque psoriasis continue to result in significant care gaps for patients, impacting outcomes and overall patient experience. As these challenges persist, a deeper understanding of the patient voice is paramount to patient care. Through a dynamic conversation between psoriasis experts and patients living with the condition, we aim to better understand the challenges that patients face and care gaps that affect their every-day life. Additionally, we will explore ongoing and future research in the psoriasis space that aims to address the barriers to care.
Sunday, March 9, 2025
Narrowing Nonmelanoma Skin Cancer Gaps With Neoadjuvant Immunotherapy: Multidisciplinary Strategies for Success
Platinum sponsor: Answers in CME Inc.
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Plaza Ballroom G
Join us for an engaging live event with Drs. David M. Miller and Vishal A. Patel, featuring patient insights from Sean Cavanaugh, as we explore groundbreaking strategies to narrow gaps in nonmelanoma skin cancer care. Learn how to integrate neoadjuvant immunotherapy into treatment plans using multidisciplinary approaches to fit your real-world practice, all driven by the latest clinical data.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Register: www.answersincme.com/MED-ONC-02318
Atopic Dermatitis Pathway Pursuit: The OX40-Ligand Edition
Platinum sponsor: Sanofi
6:30 p.m. Registration; 7 p.m. Program
Location: Hyatt (Headquarters Hotel), Plaza Ballroom H
Drs. Chovatiya, Shahriari, and Bunick will host an interactive session that focuses on the OX40-ligand pathway in atopic dermatitis (AD). This engaging discussion will delve into how targeting the OX40-ligand pathway may have the potential to help bridge treatment gaps in a highly heterogeneous patient population. The experts will provide their perspectives on some current AD clinical studies, remaining unmet needs, and future treatment goals.
Could You Be Missing Systemic Mastocytosis? The Role of the Dermatologist
Gold sponsor: Blueprint Medicines
6:30 p.m. Registration; 7 p.m. Program
Location: Convention Center, Room W221ABCDE
Take a deeper look at mast cells. Together we will follow the mast cells and uncover how these allies can become adversaries in systemic mastocytosis and other mast cell diseases.
Register: https://cvent.me/74AGrr
